Optimizing adjuvant treatment strategies for non-pancreatic periampullary cancers.

Journal: British journal of cancer
Published Date: Jul 31, 2024

Abstract

Non-pancreatic periampullary tumors have long been neglected, leading to blurred adjuvant treatment strategies. Recent research, like the ISGACA group's study, is uncovering nuances in chemotherapy efficacy for these diverse cancers. Tailored approaches show promise, with artificial intelligence (AI) aiding in personalized treatment plans.

Authors

  • Nouredin Messaoudi
    Department of Hepatopancreatobiliary Surgery, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel) and Europe Hospitals, Brussels, Belgium.
  • Aude Vanlander
    Department of Surgery, University Hospital Ghent, University of Ghent, Ghent, Belgium.
  • Andrew A Gumbs
    Centre Hospitalier Intercommunal de POISSY/SAINT-GERMAIN-EN-LAYE 10, Rue Champ de Gaillard, 78300 Poissy, France.

Keywords

External Resources

Popular Topics
Recent Journals